Mojtabai, Ramin
Stuart, Elizabeth A.
Hwang, Irving
Eaton, William W.
Sampson, Nancy
Kessler, Ronald C.
Funding for this research was provided by:
National Institute of Mental Health (R01MH096826, R01MH46376)
National Institute on Drug Abuse (R01DA012058)
Article History
Received: 13 August 2016
Accepted: 27 February 2017
First Online: 4 April 2017
Compliance with ethical standards
:
: Dr. Mojtabai has received research funding from Bristol-Myers Squibb and Lundbeck pharmaceuticals. In the past 12 months, Dr. Kessler has served as a consultant for Hoffmann-La Roche, Inc. and the Johnson & Johnson Wellness and Prevention. Dr. Kessler has served on advisory boards for Mensante Corporation, Johnson & Johnson Services Inc., Lake Nona Life Project, and U.S. Preventive Medicine. Dr. Kessler owns a 25% share in DataStat, Inc. Other authors declare no potential conflict of interest.
: Original collection of NCS and NCS-2 data has been approved by the Institutional Review Board of Harvard University and performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. The analyses reported here have been approved by the Institutional Review Board of Johns Hopkins University, Bloomberg School of Public Health. All persons interviewed for NCS and NCS-2 surveys gave their informed consent prior to their inclusion in the study.